Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitamin Classics

This article was originally published in The Tan Sheet

Executive Summary

Company is supporting January launch of Arthrita-Max Plus cooling and heating creams and gel sprays with glucosamine/chondroitin with a $1 mil. print and electronic media ad spend. Ads for the external analgesics will break in March in women's books such as Glamour, Redbook, Arthritis Today and AARP's magazine. The company also plans 10-second taglines on game shows beginning in March. The Calabasas, Calif.-based firm says the gel spray represents a new delivery system for the glucosamine/chondroitin combination; monographed active ingredients are capsaicin and eucalyptus. The 4 oz. creams and 8 oz. gel sprays, with suggested retail prices of $12.99 each, will be available in major drug and mass market outlets

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel